Evaluating the Efficacy of Autologous Blood Cell Derivative Growth Factor Concentrate-(AbcdEndosera) in Enhancing Endometrial Thickness and Live Birth Rates in Patients with Refractory Thin Endometrium

In: American Journal of Biomedical Science & Research · 2024 · vol. 22(6) , pp. 841–847 · doi:10.34297/ajbsr.2024.22.003026 · W4413248470
article OA: diamond CC0
📄 Open PDF View on OpenAlex View at publisher

Abstract

This study evaluated the effectiveness of a new treatment called ABCD-Endosera in women with thin endometrium. Thin endometrium is a condition in which the lining of the uterus is too thin, which can make it difficult to get pregnant.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK